Requires Fe2+ and ascorbate.The enzyme, which is located within the lumen of the endoplasmic reticulum, catalyses the 4-hydroxylation of prolines in -X-Pro-Gly- sequences. The 4-hydroxyproline residues are essential for the formation of the collagen triple helix. The enzyme forms a complex with protein disulfide isomerase and acts not only on procollagen but also on more than 15 other proteins that have collagen-like domains.
Requires Fe2+ and ascorbate.The enzyme, which is located within the lumen of the endoplasmic reticulum, catalyses the 4-hydroxylation of prolines in -X-Pro-Gly- sequences. The 4-hydroxyproline residues are essential for the formation of the collagen triple helix. The enzyme forms a complex with protein disulfide isomerase and acts not only on procollagen but also on more than 15 other proteins that have collagen-like domains.
i.e. HIF, an alphabetaheterodimer, in which the stability of the alpha-subunit is regulated in an oxygen-dependent manner. Hydroxylation of one or two critical proline residues in the oxygen-dependent degradation domain leads to proteasomal degradation of the protein under normic conditions, while under hypoxic conditions the oxygen-requiring hydroxylation is inhibited and HIF-alpha escapes degradation and dimerizes with HIF-beta, overview
i.e. HIF, an alphabetaheterodimer, in which the stability of the alpha-subunit is regulated in an oxygen-dependent manner. Hydroxylation of one or two critical proline residues in the oxygen-dependent degradation domain leads to proteasomal degradation of the protein under normic conditions, while under hypoxic conditions the oxygen-requiring hydroxylation is inhibited and HIF-alpha escapes degradation and dimerizes with HIF-beta, overview
might increase the enzymatic activity of prolyl 4-hydroxylases to increase type I collagen maturation. LY83583 activated prolyl 4-hydrolases differed from ascorbate-activated prolyl 4-hydroxylase in two aspects: (1) LY83583 activats both P4HA1 and P4HA2 involved in collagen maturation whereas ascorbate mainly stimulats P4HA1 in collagen maturation, (2) LY83583 does not induce N259 glycosylation on P4HA1 as ascorbate does
might increase the enzymatic activity of prolyl 4-hydroxylases to increase type I collagen maturation. LY83583 activated prolyl 4-hydrolases differs from ascorbate-activated prolyl 4-hydroxylase in two aspects: (1) LY83583 activats both P4HA1 and P4HA2 involved in collagen maturation whereas ascorbate mainly stimulats P4HA1 in collagen maturation, (2) LY83583 does not induce N259 glycosylation on P4HA1 as ascorbate does
analysis of P4Halpha1 expression during the pathological course of atherosclerotic plaque development, and effect of P4Ha1 overexpression on vulnerability of early and advanced plaque in apolipoprotein E-deficient (ApoE2/2) mice, overview
PHD1-/- mice have statistically non-significant reductions in infarct volumes following middle cerebral artery occlusion compared with their littermates at this time-point in this model
PHD2+/- mice have significantly increased microvessel density, improved cerebral blood flow on reperfusion, and show significantly better functional outcomes and higher locomotor activity associated with significantly fewer apoptotic cells in the penumbra and significantly less blood-brain-barrier disruption with a trend to reduced infarct volumes 24 h after the middle cerebral artery occlusion than littermate controls
after 2 weeks of a treatment with lentivirus-mediated P4Halpha1 construct that is transfected in carotid plaque induced in mice (atherosclerotic plaques in ApoE-/- mice) by perivascular collar placement, both early and advanced plaque exhibit stable characteristics, with increased collagen and smooth muscle cell content, reduced macrophage content, and no change in lipid content. Lenti-P4Ha1 treatment of early and advanced plaque substantially increases interstitial collagen content in the fibrous cap of plaque. It increases the carotid plaque size and the relative en face lesion area of the aorta in early but not advanced plaque, with reduced phosphatase and tensin homologue expression. The treatment reduces the expression of inflammatory cytokines and the production and activity of matrix metalloproteinase-9 and -2 in both early and advanced plaque. P4Halpha1 overexpression has a differential effect at various stages of plaque pathological progression
overexpression of prolyl-4-hydroxylase-alpha1 stabilizes but increases shear stress-induced atherosclerotic plaque in apolipoprotein E-deficient mice. After 2 weeks of lenti-P4Halpha1 treatment both low and oscillatory shear stress-induced plaques increase collagen and the thickness of fibrous cap and decreases macrophage accumulation but show no change in lipid accumulation
knockout of either P4ha1 or P4ha2 greatly reduces LY83583-stimulated type I collagen maturation whereas silencing of both P4ha1 and P4ha2 completely blocks LY83583-induced type I collagen maturation
4-hydroxylation of proline is essential for the thermal stability of collagen triple helices, non-hydroxylated collagen polypeptide chains cannot form functional molecules in vivo. The enzyme also acts as hypoxia-inducible transcription factor, HIF, and occurs in three different isozyme forms
prolyl-4-hydroxylase (P4H) plays a central role in the synthesis of all known types of collagens, which are the most abundant constituent of the extracellular matrix in atherosclerotic plaque. Isozyme P4Halpha1 is a rate-limiting enzyme and is essential for collagen maturation and secretion
prolyl-4-hydroxylase-alpha1 improves the stability of advanced plaques but accelerates the atherosclerotic lesion formation of early plaques. Analysis of P4Halpha1 expression during the pathological course of atherosclerotic plaque development, and effect of P4Ha1 overexpression on vulnerability of early and advanced plaque in apolipoprotein E-deficient (ApoE2/2) mice, overview
the beta-subunit is identical to the beta-subunit of the chaperone protein disulfide isomerase, EC 5.3.4.1. The beta-subunit is responsible for keeping the catalytic alpha-subunit active, in non-aggregated conformation and for retaining the enzyme within the lumen of the endoplasmic reticulum via its C-terminal retention signal
recombinant lentiviral-based overexpression of prolyl-4-hydroxylase-alpha1 in mice, the plaques show increased collgane accumulation but no difference of lipid accumulation. The protein expressions of TGF-beta1 are higher in lenti-P4Ha1 mice than in mock or lenti-EGFP mice. Overexpression of P4Ha1 reduced macrophage infiltration
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
separation of the enzyme from the inactive precursor of the enzyme, using ammonium sulfate precipitation and column chromatography on DEAE-Sephadex A-50 and Agarose A-1.5m columns
cloning of the alpha-I subunit and of a second mouse alpha-subunit isoform, termed the alpha-II subunit, expression of the alpha-II subunit together with human protein disulfide isomerase/beta subunit in insect cells by baculovirus vectors
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
EXPRESSION
ORGANISM
UNIPROT
LITERATURE
P4H alphaII or alphaIII null mice with 20% of wild-type enzyme activity do not show an abnormal phenotype, while P4H alpha I null mutants die at day E10.5 and show an overall developmental delay and rupture of the basement membranes due to a lack of collgane IV, overview
enzyme P4Halpha1 overexpression might be a potential therapeutic target in stabilizing vulnerable plaques to prevent rupture and erosion of atherosclerotic plaque and thus thrombosis
P4Halpha1 overexpression might be a valuable therapeutic modality in stabilizing advanced but not early plaque because of the adverse event of accelerated lesion formation
Cloning, baculovirus expression, and characterization of a second mouse prolyl 4-hydroxylase a-subunit isoform: formation of an a2b2 tetramer with the protein disulfide-isomerase/b subunit
The novel type II prolyl 4-hydroxylase is the main enzyme form in chondrocytes and capillary endothelial cells, whereas the type I enzyme predominates in most cells
Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice